Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 (Stoss Therapy) in Pediatric Patients Undergoing HSCT to Prevent Vitamin D Deficiency and Insufficiency During Transplant

NCT03176849 is registered in ClinicalTrials.gov with Phoenix Children's Hospital as lead sponsor.

NCT NCT03176849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03176849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 (Stoss Therapy) in Pediatric Patients Undergoing HSCT to Prevent Vitamin D Deficiency and Insufficiency During Transplant
Lead sponsor
Phoenix Children's Hospital
Phase
Phase 4
Overall status
Completed
Start date
November 1, 2017
Completion date
July 1, 2019
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aplastic anemia, blood disorder, myelodysplastic syndromes, pediatric acute lymphoid leukemia, pediatric acute myeloid leukemia, pediatric cancer, sickle cell anemia in children, stem cell transplant complications, thalassemia in children, vitamin d deficiency